Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: Differentiation of residual tumor from postchemoradiotherapy changes

Nuclear Medicine Communications

Volumn 34, Issue 12, 2013, Pages 1166-1173

  Choi, Hongyoon ^a   Yoon, Hai Jeon ^a   Kim, Tae Sung ^a   Oh, Jae Hwan ^a   Kim, Dae Yong ^a   Kim, Seok Ki ^a  

^a National Cancer Center   (South Korea)

Author keywords

18F FDG parametric image; 18F FDG PET CT; dual time 18F FDG PET; rectal cancer; tumor regression grade

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER REGRESSION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RECTAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887256103     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0000000000000002     Document Type: Article

References (20)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638-646.
2. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer:a multicentric phase II study. Ann Oncol 2006; 17:246-251.
3. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years:increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246:693-701.
4. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357:497-504.
5. Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006; 47:1241-1248.
6. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007; 34:1583-1593.
7. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002; 32:47-59.
8. Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62:752-760.
9. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12:19-23.
10. Haberkorn U, Strauss LG, Dimitrakopoulou A, Engenhart R, Oberdorfer F, Ostertag H, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32:1485-1490.
11. Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, et al. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using 18F-fluorodeoxyglucose- positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys 2010; 77:392-399.
12. Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging:should these be routinely employed in assessing patients with cancer? Eur J Nucl Med Mol Imaging 2007; 34:1527-1529.
13. Schillaci O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin Nucl Med 2012; 42:267-280.
14. Prieto E, Marti-Climent JM, Dominguez-Prado I, Garrastachu P, Diez-Valle R, Tejada S, et al. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation. J Nucl Med 2011; 52:865-872.
15. Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, et al. New application of dual time point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Clin Nucl Med 2013; 38:7-12.
16. Avallone A, Aloj L, Caraco C, Delrio P, Pecori B, Tatangelo F, et al. Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer:correlation with long-term outcome. Eur J Nucl Med Mol Imaging 2012; 39:1848-1857.
17. Yeung JM, Kalff V, Hicks RJ, Drummond E, Link E, Taouk Y, et al. Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome. Dis Colon Rectum 2011; 54:518-525.
18. Rosenberg R, Herrmann K, Gertler R, Kunzli B, Essler M, Lordick F, et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 2009; 24:191-200.
19. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo:high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
20. Necib H, Garcia C,Wagner A, Vanderlinden B, Emonts P, Hendlisz A, et al. Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging. J Nucl Med 2011; 52:354-361.